914 related articles for article (PubMed ID: 15850898)
21. Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Deviers A; Ken S; Filleron T; Rowland B; Laruelo A; Catalaa I; Lubrano V; Celsis P; Berry I; Mogicato G; Cohen-Jonathan Moyal E; Laprie A
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):385-93. PubMed ID: 25104068
[TBL] [Abstract][Full Text] [Related]
22. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
Stadlbauer A; Nimsky C; Buslei R; Pinker K; Gruber S; Hammen T; Buchfelder M; Ganslandt O
Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
[TBL] [Abstract][Full Text] [Related]
23. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
[TBL] [Abstract][Full Text] [Related]
25. Traumatic brain injury and subarachnoid hemorrhage: in vivo occult pathology demonstrated by magnetic resonance spectroscopy may not be "ischaemic". A primary study and review of the literature.
Macmillan CS; Wild JM; Wardlaw JM; Andrews PJ; Marshall I; Easton VJ
Acta Neurochir (Wien); 2002 Sep; 144(9):853-62; discussion 862. PubMed ID: 12376766
[TBL] [Abstract][Full Text] [Related]
26. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
27. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
[TBL] [Abstract][Full Text] [Related]
28. Quantitative proton MR spectroscopic imaging of the mesial temporal lobe.
Arslanoglu A; Bonekamp D; Barker PB; Horská A
J Magn Reson Imaging; 2004 Nov; 20(5):772-8. PubMed ID: 15503328
[TBL] [Abstract][Full Text] [Related]
29. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.
Li X; Lu Y; Pirzkall A; McKnight T; Nelson SJ
J Magn Reson Imaging; 2002 Sep; 16(3):229-37. PubMed ID: 12205577
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
Ficek K; Blamek S; Syguła D; Miszczyk L; Sońta-Jakimczyk D; Tarnawski R
Acta Neurochir Suppl; 2010; 106():195-7. PubMed ID: 19812948
[TBL] [Abstract][Full Text] [Related]
32. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
[TBL] [Abstract][Full Text] [Related]
33. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma.
Alexander A; Murtha A; Abdulkarim B; Mehta V; Wheatley M; Murray B; Riauka T; Hanson J; Fulton D; McEwan A; Roa W
Clin Invest Med; 2006 Oct; 29(5):301-11. PubMed ID: 17144440
[TBL] [Abstract][Full Text] [Related]
35. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
37. Proton magnetic resonance spectroscopy for radiation encephalopathy induced by radiotherapy for nasopharyngeal carcinoma.
Qiu SJ; Zhang XL; Zhang Y; Jiang M
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):241-6. PubMed ID: 17425962
[TBL] [Abstract][Full Text] [Related]
38. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
39. Proton magnetic resonance spectroscopy of brain-stem lesions.
Smith JK; Londono A; Castillo M; Kwock L
Neuroradiology; 2002 Oct; 44(10):825-9. PubMed ID: 12389131
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.
Sajja BR; Narayana PA; Wolinsky JS; Ahn CW;
Mult Scler; 2008 Jan; 14(1):73-80. PubMed ID: 17881390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
